Tectonic Therapeutic, Inc. — Director's Dealing 2022

Jun 17, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2022-06-08

Reporting Person: Golipour Azadeh (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	36344	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.20	2026-10-24	Common Stock (353)		Direct
Stock Option (Right to Buy)	$.91	2027-06-12	Common Stock (736)		Direct
Stock Option (Right to Buy)	$5.00	2028-03-15	Common Stock (5908)		Direct
Stock Option (Right to Buy)	$16.98	2029-02-24	Common Stock (20000)		Direct
Stock Option (Right to Buy)	$20.98	2030-03-01	Common Stock (31500)		Direct
Stock Option (Right to Buy)	$14.57	2031-01-03	Common Stock (25000)		Direct
Stock Option (Right to Buy)	$16.02	2031-02-03	Common Stock (46000)		Direct
Stock Option (Right to Buy)	$1.84	2032-02-01	Common Stock (100000)		Direct
Stock Option (Right to Buy)	$1.84	2032-02-01	Common Stock (130000)		Direct

Footnotes

F1: Consists of 36,344 RSUs granted on June 10, 2021. 50% of the shares vest on the second anniversary of the grant date and the remaining 50% vest on the third anniversary of the grant date.

F2: Fully vested.

F3: 25% of the shares vested on February 25, 2020, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.

F4: 25% of the shares vested on March 2, 2021, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.

F5: 25% of the shares vested on January 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.

F6: 25% of the shares vested on February 4, 2022, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.

F7: 25% of the shares vest on February 2, 2023, and the remaining 75% vest in equal monthly installments thereafter over a three-year period.